LY2880070

Modify Date: 2024-01-02 11:36:59

Use of LY2880070

LY2880070 is an orally active CHK1 inhibitor. LY2880070 can be used as an anticancer agent for combination with DNA damaging agents[1].

Name	(R)-N-(3-(2-methoxy-6-methylpyridin-3-yl)-1H-pyrazol-5-yl)-6-(piperidin-3-yloxy)pyrazin-2-amine

Description	LY2880070 is an orally active CHK1 inhibitor. LY2880070 can be used as an anticancer agent for combination with DNA damaging agents[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Checkpoint Kinase (Chk)
Target	1375637-35-6
References	[1]. Quincy S, et al. A phase Ib study of oral Chk1 inhibitor LY2880070 in combination with gemcitabine in patients with advanced or metastatic cancer. Journal of Clinical Oncology 2020 38:15_suppl, 3581.

Molecular Formula	C₁₉H₂₃N₇O₂
Molecular Weight	381.43

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: (R)-N-(3-(2-methoxy-6-methylpyridin-3-yl)-1H-pyrazol-5-yl)-6-(piperidin-3-yloxy)pyrazin-2-amine
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

Get all suppliers and price by the below link:

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3